Validation of an AI-Assisted Pancreatic EUS System for Training Improvement: a Prospective, Multi-Center, Randomized Trial

Launched by THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY · Jan 17, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the use of an artificial intelligence (AI) system to help improve pancreatic endoscopic ultrasound (EUS) scans, which are important tests for diagnosing pancreatic diseases. The main focus is to see how well the AI can recognize images compared to experienced endoscopists and whether it can make the scanning process better for them. Participants will either use the AI system during their scans or go without it to see which method works best.

To join the study, participants need to be between 18 and 80 years old and require an EUS scan of their pancreas. They must also be able to agree to participate and sign a consent form. However, people with certain health issues, such as severe heart problems or those who are pregnant, cannot take part. If eligible, participants can expect to undergo a standard EUS scan, which helps doctors view the pancreas better, and they will contribute to important research that could improve future diagnostic techniques.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥18 years old, \<80 years old 2.Patients who need endoscopic ultrasonography of pancreas; 3. Agree to participate in this study and sign the informed consent form.
• Exclusion Criteria:
• Subjects who meet any of the following criteria cannot be selected for this trial:
• First. The patient's physical condition does not meet the requirements of conventional endoscopic ultrasonography:
• • Poor physical condition, including hemoglobin ≤8.0g/dl, severe cardiopulmonary insufficiency, etc. Anesthesia assessment failed Pregnancy or breastfeeding In the acute stage of chemical and corrosive injury, it is very easy to cause perforation Recent acute coronary syndrome or clinically unstable ischemic heart attack Heart disease patients with right-to-left shunt, patients with severe pulmonary hypertension (pulmonary artery pressure\> 90mmHg), patients with uncontrolled systemic hypertension and patients with adult respiratory distress syndrome.
• • Second. Disagree to participate in this study.
• Third. There are other problems that do not meet the requirements of this research or that affect the results of the research:
• • Pancreatic disease has undergone surgery or radiotherapy and chemotherapy beforehand; Mental illness, drug addiction, inability to express themselves or other diseases that may affect follow-up.